The Clinical Psychopharmacology Research Program carries out clinical trials, testing new medications in patients with anxiety and depression disorders, bipolar disorders and schizophrenia.

Clinical teaching activities related to this research program involve teaching accurate diagnoses, including co-morbidity and weekly assessment of treatment using a variety of scales including the Adverse Event, HAM-A, HAM-D, YBOC, Anticipatory Anxiety and Avoidance scales, SCID and Quality of Life Scales. Students learn about the different types of clinical trials, their advantages and disadvantages. In addition, some students perform small research projects utilizing the program's large data base. Our Journal Club provides another source of learning, supplementing the daily and weekly supervisory sessions held by the program's medical director.

Current research activities include clinical trials involving new medications for generalized anxiety disorder, panic disorder, major depression, bipolar disorder and schizophrenia.